PATH | VRL
Menu

Find resources

Total results with these characteristics: 1187

Topic: Disease/vaccine specific information

Page 7 of 60
Coalition Building: A Cornerstone of National Advocacy, Policymaking and Effective Cervical Cancer Prevention Programs

This issue brief is written for civil society leaders seeking to expand access to cervical cancer prevention and control resources in their communities. These resources include HPV vaccines for young adolescents and established and new screening and …

Author: Cervical Cancer Action

A Cohort Study to Assess the New WHO Japanese Encephalitis Surveillance Standards

From the Bulletin of the World Health Organization, researchers evaluated the clinical case definition of acute encephalitis syndrome, which the standards use for identification of JE patients, to determine its sensitivity and specificity.

Author: Solomon T, Thao TT, Lewthwaite P, et al.

Publication date: 2008

Cold Chain Temperature Monitoring in Vietnam: Monitoring Ambient and Cold Chain Temperatures During Delivery of Human Papillomavirus Vaccine

This report summarizes findings from a temperature-monitoring study that gathered ambient temperature data during human papillomavirus (HPV) vaccine delivery in Vietnam. These data are compared to the known heat stability profile of the HPV vaccine …

Author: PATH, World Health Organization

Publication date: 2010

Colonisation Endpoints in Streptococcus pneumoniae Vaccine Trials

This article, published in Vaccine, reviews recent developments in the area of using colonization as an endpoint for evaluating vaccine efficacy against Streptococcus pneumoniae. The authors also provide practical guidelines for estimation methods …

Author: Auranen K, Rinta-Kokko H, Goldblatt D, et al.

Publication date: 2013

Combatting Japanese Encephalitis in Nepal: A Public Health Success Story

This case study details Nepal’s successful efforts—despite several challenges—against Japanese encephalitis (JE), from establishing disease surveillance to a robust routine JE immunization program.

Author: PATH

Publication date: 2016

A Combination Vaccine Consisting of Three Live Attenuated Enterotoxigenic Escherichia coli Strains Expressing a Range of Colonization Factors and LTB is Well Tolerated and Immunogenic in a Placebo-Controlled Double-Blind Phase 1 Trial in Healthy Adults

This article, published in Clinical and Vaccine Immunology, describes the results of a Phase 1 trial of a trivalent, live attenuated enterotoxigenic Escherichia coli vaccine candidate, ACE527. The study indicated that ACE527 had a strong safety …

Author: Harro C, Sack D, Bourgeois AL, et al.

Publication date: 2011

Combination Vaccines Against Diarrheal Diseases

This article, published in Human Vaccines & Immunotherapeutics, outlines the need for the development of affordable and effective combination vaccines against diarrheal diseases. Despite the well-documented global burden of diarrheal diseases, …

Author: Venkatesan MM, Van de Verg LL

Publication date: 2015

Communication for Polio Eradication and Routine Immunization: Checklists and Easy Reference Guides

This document provides a collection of checklists that serve as a quick-reference communications and social mobilization guide on aspects of routine immunization and disease surveillance, in addition to supplementary immunization for polio …

Author: World Health Organization, United Nations Children's Fund, US Agency for International Development

Publication date: 2002

Community Diarrhea Incidence Before and After Rotavirus Vaccine Introduction in Nicaragua

This article, published in the American Journal of Tropical Medicine and Hygiene, reports on a study that compared the incidence of diarrhea before and after the introduction of the pentavalent rotavirus vaccine in Leon, Nicaragua. The results …

Author: Becker-Dreps S, Meléndez M, Liu L, et al.

Publication date: 2013

Community Perceptions of Malaria and Vaccines in the South Coast and Busia Regions of Kenya

Malaria is a leading cause of morbidity and mortality in children younger than 5 years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria …

Author: Ba-Nguz A, Bingham A, Collymore Y, et al.

Publication date: 2011

Community Perceptions of Malaria and Vaccines in Two Districts of Mozambique

Malaria is a leading cause of mortality and morbidity in Mozambique, with nearly three-quarters of the country’s malaria-related deaths occurring in children younger than five years. A malaria vaccine is not yet available, but planning is …

Author: Bingham A, Gaspar F, Lancaster K, Conjera J, Collymore Y, Ba-Nguz A

Publication date: 2012

Comparative Evaluation of the Potential Impact of Rotavirus Versus HPV Vaccination in GAVI-Eligible Countries: A Preliminary Analysis Focused on the Relative Disease Burden

This article, published in BMC Infectious Diseases, reports on a study that aimed to provide early insight into how the comparative impact of different new vaccines could be assessed in resource-poor settings with respect to affordability, …

Author: Kim SY, Sweet S, Chang J, Goldie SJ

Publication date: 2011

Comparative Review of Three Cost-Effectiveness Models for Rotavirus Vaccines in National Immunization Programs: A Generic Approach Applied to Various Regions in the World

This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …

Author: Postma MJ, Jit M, Rozenbaum MH, Standaert BA, Tu HA, Hutubessy RCW

Publication date: 2011

Comparison of Cost-of-Illness with Willingness-to-Pay Estimates to Avoid Shigellosis: Evidence from China

Published in Health Policy and Planning, this compares cost-of-illness (COI) with stated preference estimates of willingness-to-pay associated with shigellosis in a rural area of China to evaluate the economic benefits of disease …

Author: Guh S, Xingbao C, Poulos C, et al.

Publication date: 2008

Comparison of the Immunogenicity and Safety of Measles Vaccine Administered Alone or With Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine in Philippine Infants

This article, published in the journal Vaccine, presents data generated through a PATH-supported study that demonstrated safe and immunogenic coadministration of measles vaccine and the live, attenuated japanese encephalitis vaccine. ABSTRACT …

Author: Gatchalian S, Yao Y, Zhoub B, et al.

Publication date: 2008

The Compelling Need for Game-Changing Influenza Vaccines: An Analysis of the Influenza Vaccine Enterprise and Recommendations for the Future

This report provides a review of all aspects of influenza vaccine research and development, financing, manufacturing, efficacy, safety, regulatory issues, procurement, distribution, usage, public education, consumer acceptance, and public policy. …

Author: Center for Infectious Disease Research & Policy

Publication date: 2012

Comprehensive Cervical Cancer Control: A Guide to Essential Practice - Second Edition

This publication provides a broad vision of what a comprehensive approach to cervical cancer prevention and control means. It outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the need for …

Author: World Health Organization

Publication date: 2014

Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women

This World Health Organization Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions …

Author: World Health Organization

Publication date: 2013

Concomitant Administration of Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) and Measles, Mumps, Rubella (MMR) Vaccine: Randomized Study in Toddlers in Taiwan

This article, published in Vaccine, reports on a study that examined the safety and efficacy of administering Japanese encephalitis vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine six weeks apart or concomitantly in children aged 12 to 18 …

Author: Huang L-M, Lin T-Y, Chiu C-H, et al.

Publication date: 2014

Conducting Formative Research for HPV Vaccination Program Planning: Practical Experience from PATH

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Author: PATH

Publication date: 2012

Page 7 of 60